PAB 10.0% 0.9¢ patrys limited

I am from a bio background and will be watching this company...

  1. 660 Posts.
    lightbulb Created with Sketch. 40
    I am from a bio background and will be watching this company very closely. Biologics are the future and as posted above, crossing the BBB is a huge obstacle for a lot of treatments. Glioblastomas are ugly and are usually fatal-- very quickly too. If it works in vivo and is proven safe, then this will be massive...still a lot of hurdles but plenty to like here imo.

    I also really like the emphasis on developing conjugate drugs, especially with the PARP inhibitor olaparib (https://www.globenewswire.com/en/news-release/2020/07/22/2065798/0/en/Global-PARP-Inhibitor-Market-To-Grow-At-A-CAGR-Of-27-4-Due-To-Expanding-Role-Of-PARP-Inhibitors-In-Cancer-Treatment.html). A combination therapeutic of these two could be game changing, as the majority of current treatments have terrible side effects (eg surgery, radiation and chemo +/- adjuncts).

    If it all goes to plan, PAB could potentially use deoxymab to treat a number of primary and secondary cancers, DNA diseases (eg SLE/lupus, Huntington's etc...most of these conditions are treated with drugs that have significant side effects eg methotrexate, corticosteriods.

    reminds me a bit of IHLs approach with targeted synergistic therapies. big future here imo DYOR good luck holder all that jazz
 
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.9¢
Change
-0.001(10.0%)
Mkt cap ! $18.51M
Open High Low Value Volume
1.0¢ 1.0¢ 0.9¢ $6.454K 658.9K

Buyers (Bids)

No. Vol. Price($)
17 5817122 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 2306451 4
View Market Depth
Last trade - 14.14pm 29/03/2024 (20 minute delay) ?
Last
0.9¢
  Change
-0.001 ( 10.0 %)
Open High Low Volume
1.0¢ 1.0¢ 0.9¢ 2467579
Last updated 14.14pm 29/03/2024 ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.